NCT07160829

Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 608 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a survey-based study conducted among cardiologists and nephrologists treating people with Atherosclerotic Cardiovascular Disease (ASCVD), Heart Failure (HF) and Chronic Kidney Disease (CKD). Study participants will be recruited to complete self-administered online survey. The purpose of this research is to gather real-world evidence related to attitudes around systemic inflammation and specifically the awareness, perception, drivers and barriers, and use of hsCRP in clinical practice to identify systemic inflammation in people with ASCVD+CKD and HF.

Conditions

• Atherosclerotic Cardiovascular Disease
• Heart Failure
• Chronic Kidney Disease

Interventions

Type	Name	Description
OTHER	No treatment given	No treatment given

Timeline

• Start date: 2025-09-18
• Primary completion: 2025-10-30
• Completion: 2025-10-30
• First posted: 2025-09-08
• Last updated: 2026-02-11

Locations

4 sites across 4 countries: Australia, India, South Korea, Thailand